Thursday, June 11, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 90 of 1,261
  1. WO 2024200854

    ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE

    ALK ABELLO AS [DK] · Granted Oct 3, 2024 · Expires Sep 28, 2044

    granted
  2. WO 2024206551

    COMPOSITIONS ET PROCÉDÉS DE RÉHYDRATATION D'ALGUES MARINES

    ABBOTT LAB [US] · Granted Oct 3, 2024 · Expires Sep 28, 2044

    granted
  3. AU 2023244944

    PRODRUGS OF OPICAPONE

    BIAL PORTELA & CA SA [PT] · Granted Oct 3, 2024 · Expires Sep 28, 2044

    granted
  4. US 12102637

    Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis

    Neurocrine Biosciences, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  5. US 12104165

    Adeno-associated virus with engineered capsid

    Tenaya Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  6. US 12104172

    Processes for generating TIL products enriched for tumor antigen-specific t-cells

    Iovance Biotherapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  7. US 12102682

    Injectable photothermal hydrogel based on melanin, preparation method, and application thereof

    OCEAN UNIVERSITY OF CHINA · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  8. US 12102662

    Methods for storing and warming purified corticotropin compositions

    ANI Pharmaceuticals, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  9. US 12102671

    Method of vaccination with an attenuated RSV vaccine formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  10. US 12103958

    Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions

    The Regents of the University of California · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  11. US 12102619

    Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

    JAZZ PHARMACEUTICALS RESEARCH UK LIMITED · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  12. US 12102640

    Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  13. US 12103926

    Compounds for treating huntington's disease

    PTC THERAPEUTICS, INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  14. US 12104185

    PH20 polypeptide variants, formulations and uses thereof

    HALOZYME, INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  15. US 12103960

    VEGF traps and mini-traps and methods for treating ocular disorders and cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  16. US 12102642

    Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  17. US 12104184

    PH20 polypeptide variants, formulations and uses thereof

    HALOZYME, INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  18. US 12104188

    Modified caspase-9 polypeptides and methods of use thereof

    Allogene Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  19. US 12103907

    Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

    Arcus Biosciences, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  20. US 12102688

    Immunomodulatory nanofilaments

    Stichting Radboud universitair medisch centrum · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  21. US 12102646

    Compositions for the treatment of fibrosis and inflammation

    Viking Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  22. US 12102668

    Process, tube and device for the preparation of wound healant composition

    RegenLab USA LLC · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  23. US 12102609

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  24. US 12104163

    Adeno-associated virus vectors for treatment of Rett syndrome

    Sarepta Therapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.